𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Proteomics of breast cancer for marker discovery and signal pathway profiling

✍ Scribed by Hubert Hondermarck; Anne-Sophie Vercoutter-Edouart; Françoise Révillion; Jérôme Lemoine; Ikram El-Yazidi-Belkoura; Victor Nurcombe; Jean-Philippe Peyrat

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
196 KB
Volume
1
Category
Article
ISSN
1615-9853

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer proteomics and its application to
Cancer proteomics and its application to discovery of therapy response markers in human cancer
✍ Laura Smith; Michael J. Lind; Kevin J. Welham; Lynn Cawkwell; Cancer Biology Pro 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

## Abstract The administration of chemotherapy either alone or in combination with radiotherapy is an important factor in reducing the mortality and morbidity of cancer patients. Resistance to both chemotherapy and radiotherapy represents a major obstacle to a successful outcome. The identification

Differential roles of IRS-1 and SHC sign
Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells
✍ Mary K. Nolan; Lidia Jankowska; Marco Prisco; Shi-qiong Xu; Marina A. Guvakova; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 174 KB 👁 1 views

Several polypeptide growth factors stimulate breast cancer growth and may be involved in tumor progression. However, the relative importance of diverse growth factor signaling pathways in the development and maintenance of the neoplastic phenotype is largely unknown. The activation of such growth fa

Profiling signalling pathways in formali
Profiling signalling pathways in formalin-fixed and paraffin-embedded breast cancer tissues reveals cross-talk between EGFR, HER2, HER3 and uPAR
✍ Daniela Berg; Claudia Wolff; Katharina Malinowsky; Kai Tran; Axel Walch; Holger 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 896 KB

## Abstract In the last few years, new approaches and developments in patient‐tailored cancer therapies have raised the need to select, more precisely, those patients who will respond to personalized treatments. Therefore, the most efficient way for optimal therapy and patient selection is to provi